Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders.
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
This report provides a complete quantitative data and qualitative analysis on the global market for Orthostatic Hypotension. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Orthostatic Hypotension was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Orthostatic Hypotension is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Orthostatic Hypotension, including the following market information:
Global Orthostatic Hypotension Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, Apotex, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
ECG
Blood Tests
Stress Test
Echocardiogram
Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
This report provides a complete quantitative data and qualitative analysis on the global market for Orthostatic Hypotension. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Orthostatic Hypotension was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Orthostatic Hypotension is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Orthostatic Hypotension, including the following market information:
Global Orthostatic Hypotension Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Orthostatic Hypotension Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Mylan, Roche, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, Apotex, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
ECG
Blood Tests
Stress Test
Echocardiogram
Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Orthostatic Hypotension Industry
1.7 COVID-19 Impact: Orthostatic Hypotension Market Trends
2 Global Orthostatic Hypotension Quarterly Market Size Analysis
2.1 Orthostatic Hypotension Business Impact Assessment - COVID-19
2.1.1 Global Orthostatic Hypotension Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Orthostatic Hypotension Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Orthostatic Hypotension Quarterly Market Size, 2019 VS 2020
3.2 By Players, Orthostatic Hypotension Headquarters and Area Served
3.3 Date of Key Players Enter into Orthostatic Hypotension Market
3.4 Key Players Orthostatic Hypotension Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Orthostatic Hypotension Segments, By Type
4.1 Introduction
1.4.1 ECG
1.4.2 Blood Tests
1.4.3 Stress Test
1.4.4 Echocardiogram
4.2 By Type, Global Orthostatic Hypotension Market Size, 2019-2021
5 Impact of Covid-19 on Orthostatic Hypotension Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgical Centers
5.2 By Application, Global Orthostatic Hypotension Market Size, 2019-2021
5.2.1 By Application, Global Orthostatic Hypotension Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Business Overview
7.1.2 Mylan Orthostatic Hypotension Quarterly Revenue, 2020
7.1.3 Mylan Orthostatic Hypotension Product Introduction
7.1.4 Mylan Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Orthostatic Hypotension Quarterly Revenue, 2020
7.2.3 Roche Orthostatic Hypotension Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Upsher-Smith Laboratories
7.3.1 Upsher-Smith Laboratories Business Overview
7.3.2 Upsher-Smith Laboratories Orthostatic Hypotension Quarterly Revenue, 2020
7.3.3 Upsher-Smith Laboratories Orthostatic Hypotension Product Introduction
7.3.4 Upsher-Smith Laboratories Response to COVID-19 and Related Developments
7.4 Chelsea Therapeutics
7.4.1 Chelsea Therapeutics Business Overview
7.4.2 Chelsea Therapeutics Orthostatic Hypotension Quarterly Revenue, 2020
7.4.3 Chelsea Therapeutics Orthostatic Hypotension Product Introduction
7.4.4 Chelsea Therapeutics Response to COVID-19 and Related Developments
7.5 Amgen
7.5.1 Amgen Business Overview
7.5.2 Amgen Orthostatic Hypotension Quarterly Revenue, 2020
7.5.3 Amgen Orthostatic Hypotension Product Introduction
7.5.4 Amgen Response to COVID-19 and Related Developments
7.6 Apotex
7.6.1 Apotex Business Overview
7.6.2 Apotex Orthostatic Hypotension Quarterly Revenue, 2020
7.6.3 Apotex Orthostatic Hypotension Product Introduction
7.6.4 Apotex Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Orthostatic Hypotension Industry
1.7 COVID-19 Impact: Orthostatic Hypotension Market Trends
2 Global Orthostatic Hypotension Quarterly Market Size Analysis
2.1 Orthostatic Hypotension Business Impact Assessment - COVID-19
2.1.1 Global Orthostatic Hypotension Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Orthostatic Hypotension Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Orthostatic Hypotension Quarterly Market Size, 2019 VS 2020
3.2 By Players, Orthostatic Hypotension Headquarters and Area Served
3.3 Date of Key Players Enter into Orthostatic Hypotension Market
3.4 Key Players Orthostatic Hypotension Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Orthostatic Hypotension Segments, By Type
4.1 Introduction
1.4.1 ECG
1.4.2 Blood Tests
1.4.3 Stress Test
1.4.4 Echocardiogram
4.2 By Type, Global Orthostatic Hypotension Market Size, 2019-2021
5 Impact of Covid-19 on Orthostatic Hypotension Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgical Centers
5.2 By Application, Global Orthostatic Hypotension Market Size, 2019-2021
5.2.1 By Application, Global Orthostatic Hypotension Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Business Overview
7.1.2 Mylan Orthostatic Hypotension Quarterly Revenue, 2020
7.1.3 Mylan Orthostatic Hypotension Product Introduction
7.1.4 Mylan Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Orthostatic Hypotension Quarterly Revenue, 2020
7.2.3 Roche Orthostatic Hypotension Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Upsher-Smith Laboratories
7.3.1 Upsher-Smith Laboratories Business Overview
7.3.2 Upsher-Smith Laboratories Orthostatic Hypotension Quarterly Revenue, 2020
7.3.3 Upsher-Smith Laboratories Orthostatic Hypotension Product Introduction
7.3.4 Upsher-Smith Laboratories Response to COVID-19 and Related Developments
7.4 Chelsea Therapeutics
7.4.1 Chelsea Therapeutics Business Overview
7.4.2 Chelsea Therapeutics Orthostatic Hypotension Quarterly Revenue, 2020
7.4.3 Chelsea Therapeutics Orthostatic Hypotension Product Introduction
7.4.4 Chelsea Therapeutics Response to COVID-19 and Related Developments
7.5 Amgen
7.5.1 Amgen Business Overview
7.5.2 Amgen Orthostatic Hypotension Quarterly Revenue, 2020
7.5.3 Amgen Orthostatic Hypotension Product Introduction
7.5.4 Amgen Response to COVID-19 and Related Developments
7.6 Apotex
7.6.1 Apotex Business Overview
7.6.2 Apotex Orthostatic Hypotension Quarterly Revenue, 2020
7.6.3 Apotex Orthostatic Hypotension Product Introduction
7.6.4 Apotex Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
